Confluent Medical Technologies

Confluent Medical Technologies announced a significant expansion of its Costa Rica manufacturing with a new 67,000 sq. ft. facility to increase capacity for Nitinol processing and complex catheter production. The facility is expected to be operational in the first quarter of 2022.

Confluent Medical Technologies expanded its supply agreement with Allegheny Technologies (ATI) to increase furnace capacity for ELI Nitinol at ATI's Albany, Oregon site by 33%. Confluent will fund two new melt furnaces, with additional capacity expected online in early 2022.

Confluent Medical Technologies opened a new Complex Catheter Design and Development Center in Austin, Texas, to support rapid prototyping and pilot production for electrophysiology and neurovascular catheters.

Confluent Medical Technologies is expanding its Orange County, California R&D, prototyping, and rapid development operations to support increased demand for balloon catheters, including doubling cylindrical balloon forming capacity and adding staff.

Confluent Medical Technologies, a medical device contract manufacturer, has completed the acquisition of Corpus Medical, a specialist in advanced catheter design and development. The combined company will operate as Confluent Medical Technologies.

Confluent Medical Technologies, a medical device contract manufacturer, acquired Northern Nitinol, a Minnesota-based Nitinol manufacturer specializing in rapid prototyping. The acquisition strengthens Confluent's Nitinol supply chain and adds a facility in Minneapolis.